Atlas Trials

ch14.18 Pharmacokinetic Study in High-risk Neuroblastoma

Clinical trial NCT01592045 · COMPLETED

Trial details

NCT number
NCT01592045
Sponsor
United Therapeutics
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Neuroblastoma
Start date
2012-08-01
Primary completion
2014-06-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.